Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LCTX | AMGN | VRTX | REGN | BMY |
| Company | Lineage Cell Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 0.4961 | 260.83 | 404.54 | 708.04 | 57.53 |
| High | 0.5032 | 261.53 | 407.35 | 708.97 | 57.60 |
| Low | 0.4850 | 258.50 | 399.45 | 701.20 | 56.65 |
| Last | 0.4986 | 261.32 | 402.28 | 704.29 | 56.79 |
| Change | +0.0016 | -1.33 | -6.48 | -8.11 | -0.89 |
| % Change | +0.32% | -0.51% | -1.59% | -1.14% | -1.54% |
| Volume | 1,084,817 | 567,636 | 469,015 | 140,956 | 1,688,813 |
| 20-Day Average Volume | 2,352,007 | 3,921,990 | 1,827,740 | 858,712 | 11,078,855 |
| Previous Close | 0.4970 | 262.65 | 408.76 | 712.40 | 57.68 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5404 | 269.20 | 443.03 | 738.77 | 57.63 |
| 20-Day Raw Stochastic | 14.60% | 25.90% | 23.48% | 9.44% | 35.36% |
| 20-Day Relative Strength | 37.36% | 31.38% | 32.79% | 30.42% | 50.07% |
| Weighted Alpha | -46.57 | -18.87 | -11.39 | -32.73 | +16.17 |
| Today's Opinion | 100% Sell | 88% Sell | 72% Sell | 100% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 72% Sell | 100% Sell | 80% Buy |
| Last Month's Opinion | 100% Sell | 72% Sell | 8% Sell | 88% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.16% since 12/20/24 | -0.97% since 12/20/24 | +0.94% since 12/20/24 | +0.19% since 12/20/24 | -0.88% since 12/20/24 |
| Low | 0.4850 on 12/30/24 | 258.50 on 12/30/24 | 390.92 on 12/23/24 | 701.20 on 12/30/24 | 56.65 on 12/30/24 |
| High | 0.5703 on 12/23/24 | 264.80 on 12/23/24 | 411.29 on 12/26/24 | 720.00 on 12/24/24 | 58.38 on 12/27/24 |
| 1-Month | |||||
| %Chg | -12.34% since 11/29/24 | -7.79% since 11/29/24 | -14.34% since 11/29/24 | -6.27% since 11/29/24 | -4.04% since 11/29/24 |
| Low | 0.4810 on 12/17/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 693.00 on 12/19/24 | 55.04 on 12/13/24 |
| High | 0.6200 on 12/11/24 | 282.39 on 12/02/24 | 476.46 on 12/10/24 | 800.99 on 12/09/24 | 60.09 on 12/03/24 |
| 3-Month | |||||
| %Chg | -44.63% since 09/30/24 | -19.05% since 09/30/24 | -13.78% since 09/30/24 | -33.11% since 09/30/24 | +9.83% since 09/30/24 |
| Low | 0.4810 on 12/17/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 693.00 on 12/19/24 | 51.31 on 10/15/24 |
| High | 0.9700 on 11/12/24 | 329.17 on 10/11/24 | 519.88 on 11/08/24 | 1,061.60 on 10/01/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | -49.73% since 06/28/24 | -16.52% since 06/28/24 | -14.45% since 06/28/24 | -33.10% since 06/28/24 | +36.83% since 06/28/24 |
| Low | 0.4810 on 12/17/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 693.00 on 12/19/24 | 39.35 on 07/05/24 |
| High | 1.1500 on 07/23/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 1,211.20 on 08/27/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 109,547 | 141,183,040 | 105,267,552 | 78,285,632 | 116,985,248 |
| Shares Outstanding, K | 220,416 | 537,533 | 257,529 | 109,890 | 2,028,177 |
| Annual Sales | 8,950,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -21,490,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 3,780,000 | 8,503,000,000 | 2,771,900,000 | 3,720,700,000 | 11,892,000,000 |
| Last Quarter Net Income | -3,030,000 | 2,830,000,000 | 1,045,400,000 | 1,340,600,000 | 1,211,000,000 |
| 60-Month Beta | 1.16 | 0.55 | 0.36 | 0.08 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.02 on 11/14/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 12.46 on 10/31/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/14/24 | 02/04/25 | 02/03/25 | 02/07/25 | 02/06/25 |
| Most Recent Dividend | 0.080 on 12/15/03 | 2.250 on 11/18/24 | N/A | N/A | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 02/14/25 | N/A | N/A | 01/03/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.69 | 0.00 | 17.93 | 49.57 |